Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analy...

Por Flamm, Jason A, Vanig, Thanes, Gathe, Joseph, Kinder, Clifford, Para, Michael, Rashbaum, Bruce, Segal-Maurer, Sorana, Shamblaw, David, Wohlfeiler, Michael, Young, Benjamin, Zurawski, Christine, Rhee, Martin S
Publicado no Open Forum Infect Dis (2017)

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Por Gulick, Roy M., Lalezari, Jacob, Goodrich, James, Clumeck, Nathan, DeJesus, Edwin, Horban, Andrzej, Nadler, Jeffrey, Clotet, Bonaventura, Karlsson, Anders, Wohlfeiler, Michael, Montana, John B., McHale, Mary, Sullivan, John, Ridgway, Caroline, Felstead, Steve, Dunne, Michael W., van der Ryst, Elna, Mayer, Howard
Publicado em 2008